• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625315160
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/17/2018
Event Type  malfunction  
Event Description
The customer stated that they received an erroneous result for one patient tested with a coaguchek xs meter (unknown serial number).The specific date of the event is not known.The customer stated that the event occurred a few weeks prior to (b)(6) 2018.A sample from the patient was tested using the meter, resulting with a value of 5.9 inr.Another sample was immediately collected from the patient and tested in the laboratory on a stago analyzer using neoplastin+ reagent, resulting with a value of either 3.2 inr or 3.5 inr.No adverse events were alleged to have occurred with the patient.The customer did not know if the patient had any limitations for usage of the meter.The customer did not know the patient's therapeutic range and did not know if the patient had any symptoms of bleeding or bruising.The customer did not know if the patient required treatment.The customer's product was requested for investigation.Routine retention testing is performed.Retention testing data is reviewed and appropriate actions are taken as needed.
 
Manufacturer Narrative
The customer did not return any materials for investigation.Without these materials to investigate, a specific root cause could not be determined.Coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8203948
MDR Text Key131718803
Report Number1823260-2018-05170
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 04/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04625315160
Device Lot NumberASKU
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/17/2018
Initial Date FDA Received12/28/2018
Supplement Dates Manufacturer Received12/17/2018
Supplement Dates FDA Received04/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-